Yougov Plc · LSE:YOU
Yougov — Investor Presentation (February 2026)
11 slides from Yougov's investor presentation, February 2026
Slide 1: The new health and wellbeing consumer
UNITED KINGDOM The new health and wellbeing consumer YouGov Syndicated tracker webinar February 2026
Slide 2: YouGov Health & Wellbeing tracker
2 Understanding the new health and wellbeing consumer YouGov Health & Wellbeing tracker Our newest syndicated tracker – delivered by YouGov, shaped by its members Who we speak to every quarter: Including natural fallout of ~2,000 UK 18+ nat rep weight loss drug and other cosmetic treatment users Boo
Slide 3: Currently do / have tried wellness trends
3 Understanding the new health and wellbeing consumer Currently do / have tried wellness trends Currently do Done in past Dietary supplements 44% 22% 66% Intermittent fasting 9% 23% 32% Journaling 8% 20% 28% Meal replacement drinks 5% 19% 24% CBD-containing products 4% 14% 18% 81% Have tried at leas
Slide 4: There is interest in trying new things
4 Understanding the new health and wellbeing consumer 55% agree “I try to ensure I consume my '5-a-day' 23% agree “I don't care much about what's in my food if it 24% disagree fruit and vegetables” 55% disagree tastes good” 45% agree “Fresh food is healthier Many assume that 23% than frozen food” fr
Slide 5: 8% have used weight loss drugs – equivalent to 4.3 million people
5 Understanding the new health and wellbeing consumer 8% have used weight loss drugs – equivalent to 4.3 million people 14% would consider using weight loss drugs in the future – equivalent to 7.6 million people Source: YouGov Health & Wellbeing tracker: December 2025 Which, if any, of the following
Slide 6: Awareness of weight loss drugs: injectable and non-injectable
6 Understanding the new health and wellbeing consumer 69% 47% Weight loss injections Non-injectable weight loss drugs Ozempic (semaglutide) 55% Orlistat 9% Alli (orlistat) 6% Mounjaro (tirzepatide) 49% Xenical 5% (orlistat) Wegovy (semaglutide) 27% Rybelsus (semaglutide) 4% Saxenda (liraglutide) 4%
Slide 7: An easy journey…
7 Understanding the new health and wellbeing consumer An easy journey… Ease of weight loss drug journey 92% 83% 85% 76% 80% 65% 64% 57% Easy Difficult 8% 4% 6% 4% 8% 8% 18% 14% Deciding that Finding Speaking to a GP Getting the Taking the Starting and Managing side Maintaining weight loss informatio
Slide 8: … until it comes to stopping
8 Understanding the new health and wellbeing consumer … until it comes to stopping Ease of weight loss drug journey – those not used weight loss drugs in last month 69% 26% Easy 12% Difficult 37% Stopping using weight loss drugs Maintaining weight after stopping using weight loss drugs Source: YouGo
Slide 9: What do consumers think of cosmetic treatments?
9 Understanding the new health and wellbeing consumer What do consumers think of cosmetic treatments? Agree Neither/Don't know Disagree Cosmetic treatments have become more socially acceptable in recent 67% 28% 6% years Cosmetic treatments are for men and women 66% 28% 6% Cosmetic treatments are as
Slide 10: Since treatment…
10 Understanding the new health and wellbeing consumer Since treatment… I have recommended this treatment to others 33% I have had positive comment(s) from others 29% following this treatment 68% Rate satisfaction with their treatment 8, 9 or 10 out of I have looked into other treatment(s) 11% 10 I
Slide 11: Thank you
Thank you /Research Reality YouGov, 2025, all rights reserved. All materials contained herein are protected by copyright laws. Any storage, reproduction or distribution of such materials, in whole or in part, in any form without the prior written permission of YouGov is prohibited. This information